Glass-liquid phase separation in highly supersaturated aqueous solutions of telaprevir

Molecular Pharmaceutics

Volumn 12, Issue 2, 2015, Pages 496-503

  Mosquera Giraldo, Laura I ^a   Taylor, Lynne S ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

maximum solution concentration; precipitation; Supersaturation; telaprevir

Indexed keywords

TELAPREVIR; OLIGOPEPTIDE; SOLUTION AND SOLUBILITY;

AQUEOUS SOLUTION; ARTICLE; CALORIMETRY; CONTROLLED STUDY; CRYSTALLIZATION; DRUG CONCENTRATION; DRUG SOLUBILITY; DRUG SOLUTION; DYNAMIC LIGHT SCATTERING; ENTHALPY; FLUORESCENCE SPECTROSCOPY; GLASS LIQUID PHASE SEPARATION; GLASS TRANSITION TEMPERATURE; LIGHT SCATTERING; PHASE SEPARATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY; CHEMISTRY; MEDICINAL CHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHASE TRANSITION; PROCEDURES; SOLUBILITY; SOLUTION AND SOLUBILITY; TRANSITION TEMPERATURE;

CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; MAGNETIC RESONANCE SPECTROSCOPY; OLIGOPEPTIDES; PHARMACEUTICAL SOLUTIONS; PHASE TRANSITION; SOLUBILITY; TRANSITION TEMPERATURE;

EID: 84922142661     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500573z     Document Type: Article

References (35)

1. Williams, H. D.; Trevaskis, N. L.; Charman, S. A.; Shanker, R. M.; Charman, W. N.; Pouton, C. W.; Porter, C. J. H. Strategies to Address Low Drug Solubility in Discovery and Development Pharmacol. Rev. 2013, 65, 315-499
2. Otsuka, M.; Kaneniwa, N. A Kinetic Study of the Crystallization Process of Noncrystalline Indomethacin under Isothermal Conditions Chem. Pharm. Bull. 1988, 36, 4026-4032
3. Kestur, U. S.; Taylor, L. S. Role of Polymer Chemistry in Influencing Crystal Growth Rates from Amorphous Felodipine CrystEngComm 2010, 12, 2390-2397
4. Van den Mooter, G.; Wuyts, M.; Blaton, N.; Busson, R.; Grobet, P.; Augustijns, P.; Kinget, R. Physical Stabilisation of Amorphous Ketoconazole in Solid Dispersions with Polyvinylpyrrolidone K25 Eur. J. Pharm. Sci. 2001, 12, 261-269
5. Khougaz, K.; Clas, S.-D. Crystallization Inhibition in Solid Dispersions of MK-0591 and Poly(vinylpyrrolidone) Polymers J. Pharm. Sci. 2000, 89, 1325-1334
6. Bevernage, J.; Hens, B.; Brouwers, J.; Tack, J.; Annaert, P.; Augustijns, P. Supersaturation in Human Gastric Fluids Eur. J. Pharm. Biopharm. 2012, 81, 184-189
7. Frank, K. J.; Rosenblatt, K. M.; Westedt, U.; Hölig, P.; Rosenberg, J.; Mägerlein, M.; Fricker, G.; Brandl, M. Amorphous Solid Dispersion Enhances Permeation of Poorly Soluble ABT-102: True Supersaturation vs. Apparent Solubility Enhancement Int. J. Pharm. 2012, 437, 288-293
8. Brick, M. C.; Palmer, H. J.; Whitesides, T. H. Formation of Colloidal Dispersions of Organic Materials in Aqueous Media by Solvent Shifting Langmuir 2003, 19, 6367-6380
9. Seidler, J.; McGovern, S.; Doman, T. N.; Shoichet, B. K. Identification and Prediction of Promiscuous Aggregating Inhibitors among Known Drugs J. Med. Chem. 2003, 4477-4486
10. Coan, K. E. D.; Shoichet, B. K. Stoichiometry and Physical Chemistry of Promiscuous Aggregate-Based Inhibitors J. Am. Chem. Soc. 2008, 130, 9606-9612
11. Ilevbare, G. A.; Taylor, L. S. Liquid-Liquid Phase Separation in Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs: Implications for Solubility Enhancing Formulations Cryst. Growth Des. 2013, 13, 1497-1509
12. Frenkel, Y. V.; Clark, A. D.; Das, K.; Wang, Y.-H.; Lewi, P. J.; Janssen, P. a J.; Arnold, E. Concentration and pH Dependent Aggregation of Hydrophobic Drug Molecules and Relevance to Oral Bioavailability J. Med. Chem. 2005, 48, 1974-1983
13. Raina, S. A.; Zhang, G. G. Z.; Alonzo, D. E.; Wu, J.; Zhu, D.; Catron, N. D.; Gao, Y.; Taylor, L. S. Enhancements and Limits in Drug Membrane Transport Using Supersaturated Solutions of Poorly Water-Soluble Drugs J. Pharm. Sci. 2014, 103, 2736-2748
14. Kwong, A. D.; Kauffman, R. S.; Hurter, P.; Mueller, P. Discovery and Development of Telaprevir: An NS3-4A Protease Inhibitor for Treating Genotype 1 Chronic Hepatitis C Virus Nat. Biotechnol. 2011, 29, 993-1003
15. ChEMBL. EMBL-EBI. Compound Report, Compound ID CHEMBL231813, Telaprevir. http://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL231813 (accessed Apr 10, 2014).
16. Murdande, S. B.; Pikal, M. J.; Shanker, R. M.; Bogner, R. H. Solubility Advantage of Amorphous Pharmaceuticals: I. A Thermodynamic Analysis J. Pharm. Sci. 2010, 99, 1254-1264
17. Hoffman, J. D. Thermodynamic Driving Force in Nucleation and Growth Processes J. Chem. Phys. 1958, 29, 1192
18. Hsieh, Y.-L.; Ilevbare, G.; Van Eerdenbrugh, B.; Box, K.; Sanchez-Felix, M.; Taylor, L. S. pH-Induced Precipitation Behavior of Weakly Basic Compounds: Determination of Extent and Duration of Supersaturation Using Potentiometric Titration and Correlation to Solid State Properties Pharm. Res. 2012, 29, 2738-2753
19. Andronis, V.; Yoshioka, M.; Zografi, G. Effects of Sorbed Water on the Crystallization of Indomethacin from the Amorphous State J. Pharm. Sci. 1997, 86, 346-351
20. Marsac, P.; Konno, H.; Taylor, L. S. A Comparison of the Physical Stability of Amorphous Felodipine and Nifedipine Systems Pharm. Res. 2006, 23, 2306-2316
21. Lakowics, J. R. Principles of Fluorescence Spectroscopy, 3 rd ed.; Springer: New York, 2011.
22. Cichos, F.; Willert, A.; Rempel, U. Solvation Dynamics in Mixtures of Polar and Nonpolar Solvents J. Phys. Chem. A 1997, 5639, 8179-8185
23. Sýkora, J.; Slavícek, P.; Jungwirth, P.; Barucha, J.; Hof, M. Time-Dependent Stokes Shifts of Fluorescent Dyes in the Hydrophobic Backbone Region of a Phospholipid Bilayer: Combination of Fluorescence Spectroscopy and Ab Initio Calculations J. Phys. Chem. B 2007, 111, 5869-5877
24. LaPlante, S. R.; Carson, R.; Gillard, J.; Aubry, N.; Coulombe, R.; Bordeleau, S.; Bonneau, P.; Little, M.; OMeara, J.; Beaulieu, P. L. Compound Aggregation in Drug Discovery: Implementing a Practical NMR Assay for Medicinal Chemists J. Med. Chem. 2013, 56, 5142-5150
25. Zerbe, Oliver.; Jurt, S. Applied NMR Spectoscopy for Chemist and Life Science; Wiley-VCH: Weinheim, Germany, 2014; pp 20-22.
26. Bagchi, B. Molecular Relaxation in Liquids; Oxford University Press: Oxford, U. K., 2012; p 37.
27. Resing, H. A. Apparent Phase-Transition Effect in the N.M.R. Spin-Spin Relaxation Time Caused by a Distribution of Correlation Times J. Chem. Phys. 1965, 43, 669-678
28. Davis, A. F.; Hadgraft, J. Effect of Supersaturation on Membrane Transport: 1. Hydrocortisone Acetate Int. J. Pharm. 1991, 76, 1-8
29. Takano, R.; Takata, N.; Saito, R.; Furumoto, K.; Higo, S.; Hayashi, Y.; Machida, M.; Aso, Y.; Yamashita, S. Quantitative Analysis of the Effect of Supersaturation on in Vivo Drug Absorption Mol. Pharmaceutics 2010, 7, 1431-1440
30. Gao, Y.; Carr, R. A.; Spence, J. K.; Wang, W. W.; Turner, T. M.; Lipari, J. M.; Miller, J. M. A pH-Dilution Method for Estimation of Biorelevant Drug Solubility along the Gastrointestinal Tract: Application to Physiologically Based Pharmacokinetic Modeling Mol. Pharmaceutics 2010, 7, 1516-1526
31. Bonnett, P. E.; Carpenter, K. J.; Dawson, S.; Davey, R. J. Solution Crystallisation via a Submerged Liquid-Liquid Phase Boundary: Oiling Out Chem. Commun. (Cambridge, U. K.) 2003, 698-699
32. Brečević, L.; Nielsen, A. E. Solubility of Amorphous Calcium Carbonate J. Cryst. Growth 1989, 98, 504-510
33. Söhnel, O.; Mullin, J. W. Precipitation of Calcium Carbonate J. Cryst. Growth 1982, 60, 239-250
34. Addadi, L.; Raz, S.; Weiner, S. Taking Advantage of Disorder: Amorphous Calcium Carbonate and Its Roles in Biomineralization Adv. Mater. 2003, 15, 959-970
35. Friesen, D. T.; Shanker, R.; Crew, M.; Smithey, D. T.; Curatolo, W. J.; Nightingale, J. A. S. Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview Mol. Pharmaceutics 2008, 5, 1003-1019